Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, indicating a new build/maintenance update of the ClinicalTrials.gov page. This update does not alter the study content or data displayed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision tag updated from v3.6.2 to v3.6.3, indicating a minor page update. No study information or functionality is affected.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays a newer revision tag (v3.6.2) replacing the previous v3.6.0, indicating a software/system update for the page.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a Revision: v3.6.0 notice. The 'Intervention / Treatment' label was reformatted to 'Intervention/Treatment' and the older 'Revision: v3.5.5' note was removed.SummaryDifference0.5%

- Check60 days agoChange DetectedA new page revision tag v3.5.5 has been added, replacing the previous v3.5.4 to reflect an update to the page's documentation/UI.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a new revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3'. This reflects a backend page revision update rather than any change to study data or content.SummaryDifference0.1%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.